• Je něco špatně v tomto záznamu ?

Impact of methylprednisolone in priming solution of cardiopulmonary bypass on anti-inflammatory CD163 receptor during cardiac surgery

J. Krejsek, J. Mandak, P. Kunes, V. Lonsky, M. Kolackova, K. Jankovicova, C. Andrys,

. 2012 ; 27 (4) : 284-91.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu klinické zkoušky, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13000944
E-zdroje Online Plný text

NLK ProQuest Central od 1997-01-01 do 2015-11-30
SAGE Publications Journals od 1999-01-01 do 2015-12-31
CINAHL Plus with Full Text (EBSCOhost) od 1997-01-01 do 2016-05-31
Medline Complete (EBSCOhost) od 1997-01-01 do 2016-05-31
Nursing & Allied Health Database (ProQuest) od 1997-01-01 do 2015-11-30
Health & Medicine (ProQuest) od 1997-01-01 do 2015-11-30
SAGE Journals od 2012-01-01 do 2012-05-31

We evaluated the influence of methylprednisolone in cardiopulmonary bypass fluid on scavenger receptor for hemoglobin CD163 molecule expression on monocytes of patients who underwent elective coronary artery bypass grafting with cardiopulmonary bypass with either exposure to methylprednisolone present in the cardiopulmonary bypass fluid (20 patients), or without methylprednisolone in the cardiopulmonary bypass fluid (22 patients) and operated on without cardiopulmonary bypass (42 patients). The dynamics of CD163 expression was also followed in patients operated on without cardiopulmonary bypass. This study was a retrospective analysis of a comparison of two studies. The expression of CD163 was determined quantitatively by standardized flow cytometry technique. The similarities in the dynamics of CD163 monocyte expression, comparing the patients operated on with or without cardiopulmonary bypass, were found. Compared to the preoperative level, CD163 monocyte expression was significantly elevated on the 1(st) postoperative day. Monocyte CD163 expression on the 1(st) postoperative day was evidently similar in both groups of patients operated without cardiopulmonary bypass (median value of mean fluorescence intensity (MFI) 18,896; interquartile range from 27,538 to 57,711; median value of MFI 18,863; interquartile range from 16,514 to 26,559; n.s.), suggesting high reproducibility of our flow cytometric method; the monocyte CD163 expression was significantly higher (median value of MFI 37,902; interquartile range from 27,538 to 57,711) on the 1(st) postoperative day in patients exposed to methylprednisolone compared to patients without this exposure (median value of MFI 20,995; interquartile range from 16,321 to 29,623) (p<0.001). We concluded that the expression of hemoglobin scavenger receptor CD163 on monocytes of cardiac surgical patients is induced by methylprednisolone present in cardiopulmonary bypass fluid.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13000944
003      
CZ-PrNML
005      
20171210094319.0
007      
ta
008      
130108s2012 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1177/0267659112439595 $2 doi
035    __
$a (PubMed)22354894
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Krejsek, J $u Department of Clinical Immunology and Allergology, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Kralove, Czech Republic. krejsek@fnhk.cz
245    10
$a Impact of methylprednisolone in priming solution of cardiopulmonary bypass on anti-inflammatory CD163 receptor during cardiac surgery / $c J. Krejsek, J. Mandak, P. Kunes, V. Lonsky, M. Kolackova, K. Jankovicova, C. Andrys,
520    9_
$a We evaluated the influence of methylprednisolone in cardiopulmonary bypass fluid on scavenger receptor for hemoglobin CD163 molecule expression on monocytes of patients who underwent elective coronary artery bypass grafting with cardiopulmonary bypass with either exposure to methylprednisolone present in the cardiopulmonary bypass fluid (20 patients), or without methylprednisolone in the cardiopulmonary bypass fluid (22 patients) and operated on without cardiopulmonary bypass (42 patients). The dynamics of CD163 expression was also followed in patients operated on without cardiopulmonary bypass. This study was a retrospective analysis of a comparison of two studies. The expression of CD163 was determined quantitatively by standardized flow cytometry technique. The similarities in the dynamics of CD163 monocyte expression, comparing the patients operated on with or without cardiopulmonary bypass, were found. Compared to the preoperative level, CD163 monocyte expression was significantly elevated on the 1(st) postoperative day. Monocyte CD163 expression on the 1(st) postoperative day was evidently similar in both groups of patients operated without cardiopulmonary bypass (median value of mean fluorescence intensity (MFI) 18,896; interquartile range from 27,538 to 57,711; median value of MFI 18,863; interquartile range from 16,514 to 26,559; n.s.), suggesting high reproducibility of our flow cytometric method; the monocyte CD163 expression was significantly higher (median value of MFI 37,902; interquartile range from 27,538 to 57,711) on the 1(st) postoperative day in patients exposed to methylprednisolone compared to patients without this exposure (median value of MFI 20,995; interquartile range from 16,321 to 29,623) (p<0.001). We concluded that the expression of hemoglobin scavenger receptor CD163 on monocytes of cardiac surgical patients is induced by methylprednisolone present in cardiopulmonary bypass fluid.
650    _2
$a senioři $7 D000368
650    _2
$a antiflogistika $x aplikace a dávkování $7 D000893
650    _2
$a CD antigeny $x biosyntéza $7 D015703
650    _2
$a antigeny diferenciační myelomonocytární $x biosyntéza $7 D015214
650    _2
$a kardiopulmonální bypass $7 D002315
650    _2
$a koronární bypass $7 D001026
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a regulace genové exprese $x účinky léků $7 D005786
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a methylprednisolon $x aplikace a dávkování $7 D008775
650    _2
$a monocyty $x metabolismus $7 D009000
650    _2
$a pooperační období $7 D011184
650    _2
$a receptory buněčného povrchu $x biosyntéza $7 D011956
655    _2
$a klinické zkoušky $7 D016430
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Mandak, J
700    1_
$a Kunes, P
700    1_
$a Lonsky, V
700    1_
$a Kolackova, M
700    1_
$a Jankovicova, K
700    1_
$a Andrýs, Ctirad $7 mzk2008430528 $4
773    0_
$w MED00003752 $t Perfusion $x 1477-111X $g Roč. 27, č. 4 (2012), s. 284-91
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22354894 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20130108 $b ABA008
991    __
$a 20130111093010 $b ABA008
999    __
$a ok $b bmc $g 963726 $s 799108
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 27 $c 4 $d 284-91 $i 1477-111X $m Perfusion $n Perfusion $x MED00003752
LZP    __
$a Pubmed-20130108

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...